Two repurposed drugs and a blue dye show potential as SARS-CoV-2 entry inhibitors
Two repurposed drugs and a blue dye show potential as SARS-CoV-2 entry inhibitors A new multidisciplinary study from Australia, published in the open-access journal mBio, shows that three compounds used to treat cystic fibrosis, dry eye, and a specific medical dye may lead to future strategies for the treatment of coronavirus disease (COVID-19). The ongoing pandemic of COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents a health emergency that necessitates the continued use of vaccines, but also the development of new drugs to prevent or treat thi...
Source: news-medical.net
